|
SkyePharma PLC - Comparative Business Analysis Snapshot
Business Description
SkyePharma PLC. The Group's principal activity is researching and developing, manufacturing and selling prescription pharmaceutical products. It uses multiple drug delivery technologies to create a product pipeline for out-licensing to marketing partners. Its product brands include Flutiform, Foradil Certihaler, Paxil CR, Xatral OD, Solaraze, Triglide, Lodotra, Requip Once-a-day, Sular and ZYFLO CR. The Group's product pipelines are oral, inhalation, injectable, topical and solubilisation.
Competitor Analysis
This analysis compares SkyePharma PLC with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
